| Product Code: ETC7904514 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Antithrombotic Drugs Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Antithrombotic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Antithrombotic Drugs Market - Industry Life Cycle |
3.4 Latvia Antithrombotic Drugs Market - Porter's Five Forces |
3.5 Latvia Antithrombotic Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Antithrombotic Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Latvia Antithrombotic Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Latvia Antithrombotic Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Latvia Antithrombotic Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Latvia Antithrombotic Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Latvia Antithrombotic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Latvia |
4.2.2 Growing awareness about the importance of antithrombotic drugs in preventing blood clots |
4.2.3 Advancements in healthcare infrastructure and technology in Latvia |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and marketing |
4.3.2 High cost associated with antithrombotic drugs |
4.3.3 Potential side effects and risks associated with prolonged use of antithrombotic drugs |
5 Latvia Antithrombotic Drugs Market Trends |
6 Latvia Antithrombotic Drugs Market, By Types |
6.1 Latvia Antithrombotic Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Antithrombotic Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Latvia Antithrombotic Drugs Market Revenues & Volume, By Apixaban, 2021- 2031F |
6.1.4 Latvia Antithrombotic Drugs Market Revenues & Volume, By Debigatran, 2021- 2031F |
6.1.5 Latvia Antithrombotic Drugs Market Revenues & Volume, By Edoxaban, 2021- 2031F |
6.1.6 Latvia Antithrombotic Drugs Market Revenues & Volume, By Fondaparinux, 2021- 2031F |
6.1.7 Latvia Antithrombotic Drugs Market Revenues & Volume, By Heparin, 2021- 2031F |
6.1.8 Latvia Antithrombotic Drugs Market Revenues & Volume, By Rivaroxaban, 2021- 2031F |
6.2 Latvia Antithrombotic Drugs Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Latvia Antithrombotic Drugs Market Revenues & Volume, By Thrombolytic Drugs, 2021- 2031F |
6.2.3 Latvia Antithrombotic Drugs Market Revenues & Volume, By Anti-Platelet Drugs, 2021- 2031F |
6.2.4 Latvia Antithrombotic Drugs Market Revenues & Volume, By Anticoagulants, 2021- 2031F |
6.2.5 Latvia Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Latvia Antithrombotic Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Latvia Antithrombotic Drugs Market Revenues & Volume, By Atrial Fibrillation, 2021- 2031F |
6.3.3 Latvia Antithrombotic Drugs Market Revenues & Volume, By Stroke, 2021- 2031F |
6.3.4 Latvia Antithrombotic Drugs Market Revenues & Volume, By Deep vein thrombosis (DVT), 2021- 2031F |
6.3.5 Latvia Antithrombotic Drugs Market Revenues & Volume, By Pulmonary Embolism (PE), 2021- 2031F |
6.3.6 Latvia Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Latvia Antithrombotic Drugs Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Latvia Antithrombotic Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Latvia Antithrombotic Drugs Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.4 Latvia Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Latvia Antithrombotic Drugs Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Latvia Antithrombotic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Latvia Antithrombotic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Latvia Antithrombotic Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 Latvia Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Latvia Antithrombotic Drugs Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Latvia Antithrombotic Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Latvia Antithrombotic Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Latvia Antithrombotic Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 Latvia Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Antithrombotic Drugs Market Import-Export Trade Statistics |
7.1 Latvia Antithrombotic Drugs Market Export to Major Countries |
7.2 Latvia Antithrombotic Drugs Market Imports from Major Countries |
8 Latvia Antithrombotic Drugs Market Key Performance Indicators |
8.1 Patient adherence rate to antithrombotic drug therapy |
8.2 Number of healthcare facilities offering antithrombotic treatments |
8.3 Rate of new product development and innovation in the antithrombotic drug market |
9 Latvia Antithrombotic Drugs Market - Opportunity Assessment |
9.1 Latvia Antithrombotic Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Antithrombotic Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Latvia Antithrombotic Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Latvia Antithrombotic Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Latvia Antithrombotic Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Latvia Antithrombotic Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Latvia Antithrombotic Drugs Market - Competitive Landscape |
10.1 Latvia Antithrombotic Drugs Market Revenue Share, By Companies, 2024 |
10.2 Latvia Antithrombotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here